Takeda’s Take On Patent Certification Rules In Colchicine Dispute Rejected

A federal judge tosses Takeda’s suit against FDA, finding Hikma did not need to reference Takeda’s Colcrys or certify Colcrys patents to obtain approval of its colchicine product.